Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
If genetic testing reveals reduced GLP-1 receptor sensitivity, switching to PlexusDx GLP-Squared Injection (combining semaglutide and tirzepatide, at $289/mo month-to-month, or from $249/mo on the 6-month plan) activates dual pathwaysGLP-1 and GIPfor additive appetite suppression
Cash at 3Q25 was $170mm, putting net leverage around 1.6x against FY25 EBITDA guidance of $145-150mm
As for diabetic PDA patients, insulin is a definite tumor-promoting factor
Many Californians using GLP-1 medications are hearing about maintenance doses, micro-dosing, and tapering plans but arent sure how they work or whether theyre necessary
Statements Author contributions XuW: Writing original draft, Writing review & editing
US$ 23.69
US$ 21.75
US$ 26.53
US$ 22.39
